Andrea Schiefer
Overview
Explore the profile of Andrea Schiefer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Behrmann L, Lammer C, Schiefer A, Neufeld H, Grosse M, Stadler M, et al.
Int J Antimicrob Agents
. 2024 Sep;
64(5):107344.
PMID: 39321893
No abstract available.
2.
Behrmann L, Meier K, Vollmer J, Chiedu C, Schiefer A, Hoerauf A, et al.
Front Microbiol
. 2024 Aug;
15:1405287.
PMID: 39091298
Obligate intracellular endobacteria of the genus are widespread in arthropods and several filarial nematodes. Control programs for vector-borne diseases (dengue, Zika, malaria) and anti-filarial therapy with antibiotics are based on...
3.
Balthazar J, Golparian D, Unemo M, Read T, Grosse M, Stadler M, et al.
Microbiol Spectr
. 2024 Jul;
12(8):e0140624.
PMID: 38946026
No abstract available.
4.
Lockener I, Behrmann L, Reuter J, Schiefer A, Klockner A, Krannich S, et al.
Antibiotics (Basel)
. 2024 May;
13(5).
PMID: 38786149
Chlamydial infections and diseases caused by filarial nematodes are global health concerns. However, treatment presents challenges due to treatment failures potentially caused by persisting and long regimens against filarial infections...
5.
Balthazar J, Golparian D, Unemo M, Read T, Grosse M, Stadler M, et al.
Microbiol Spectr
. 2024 Apr;
12(6):e0056024.
PMID: 38647280
Importance: The continued emergence of multi-antibiotic-resistant strains of necessitates the development of new antibiotics that are effective against this human pathogen. We previously described that the RNA polymerase-targeting antibiotic corallopyronin...
6.
Becker T, Heitkotter J, Krome A, Schiefer A, Pfarr K, Ehrens A, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543280
Toxicological studies are a part of the drug development process and the preclinical stages, for which suitable vehicles ensuring easy and safe administration are crucial. However, poor aqueous solubility of...
7.
Miethke M, Pieroni M, Weber T, Bronstrup M, Hammann P, Halby L, et al.
Nat Rev Chem
. 2023 Apr;
5(10):726-749.
PMID: 37118182
An ever-increasing demand for novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant bacterial pathogens stands in stark contrast to the current level of investment in...
8.
Rox K, Becker T, Schiefer A, Grosse M, Ehrens A, Jansen R, et al.
Pharmaceutics
. 2023 Jan;
15(1).
PMID: 36678760
Methicillin-resistant Staphylococcus aureus (MRSA) is a World Health Organization’s high priority pathogen organism, with an estimated > 100,000 deaths worldwide in 2019. Thus, there is an unmet medical need for...
9.
Edwards J, Balthazar J, Esposito D, Ayala J, Schiefer A, Pfarr K, et al.
mSphere
. 2022 Sep;
7(5):e0036222.
PMID: 36094073
Gonorrhea remains a major global public health problem because of the high incidence of infection (estimated 82 million cases in 2020) and the emergence and spread of Neisseria gonorrhoeae strains...
10.
Becker T, Krome A, Vahdati S, Schiefer A, Pfarr K, Ehrens A, et al.
Pharmaceutics
. 2022 Aug;
14(8).
PMID: 36015283
In vivo studies in mice provide a valuable model to test novel active pharmaceutical ingredients due to their low material need and the fact that mice are frequently used as...